Akston Biosciences Launches Phase I/II Clinical Trial of COVID-19 Vaccine shelf-stable for 4 months at temperatures up to 25°C (77°F)
First subjects dosed with AKS-452, COVID-19 vaccine candidate in the Netherlands trial Vaccine is shelf-stable for ...
Read more